• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

多层面干预方案 - 一项旨在降低儿科急症和血液肿瘤病房中心静脉相关血流感染率的质量改进计划。

Multi-level Intervention Program - A Quality Improvement Initiative to Decrease Central Line-Associated Bloodstream Infections in the Pediatric Acute and Hematology/Oncology Units.

机构信息

UCLA School of Nursing, Los Angeles, CA, United States of America.

UCLA Mattel Children's Hospital, Los Angeles, CA, United States of America.

出版信息

J Pediatr Nurs. 2019 Sep-Oct;48:106-113. doi: 10.1016/j.pedn.2019.07.002. Epub 2019 Aug 1.

DOI:10.1016/j.pedn.2019.07.002
PMID:31377635
Abstract

INTRODUCTION

Central Venous Catheters (CVCs) are placed in pediatric patients that require frequent and/or long-term access for intravenous treatments and increase the risk for Central line-associated bloodstream infections (CLABSIs). The specific aims of the study were to evaluate adherence to the intervention components and rates of Central Line Associated Bloodstream Infections (CLABSIs) over five years.

METHODS

Implementation occurred on the acute care and hematology-oncology pediatric units of a quaternary health care setting in Southern California. Adherence rates were quantified using a CVC audit sheet and CLABSI rates were obtained quarterly before, and at year 1, 2, 3, 4, 5 of implementation.

RESULTS

CLABSI rates for both pediatric units decreased over the five-year period. Adherence rates were 90% to 100% on the different features of the intervention; the lowest was adherence to Patient Protective Equipment (PPE). A total of 41 incidents of hospital-acquired CLABSIs were reported the year prior to the Bug Buster Committee, which decreased steadily to 9 incidents after implementation. The quarterly CLABSI rates in the Pediatric Acute Care ranged from 2.8 to 6.6/1,000 catheter days and in Pediatric Hematology-Oncology from 2.1 to 4.3/1,000 catheter days the year prior to implementation.

CONCLUSIONS

While adherence for staff remains high, parent/family adherence was low. We recommend including in the multi-level intervention, procedures targeting parent adherence such as patient education handouts, reviewing content on admission, placing signs on doors indicating PPE requirements, and promptly providing PPE to non-adherent family members.

摘要

简介

中心静脉导管(CVC)用于需要频繁和/或长期静脉治疗的儿科患者,增加了中心导管相关血流感染(CLABSI)的风险。该研究的具体目的是评估干预措施各组成部分的依从性以及五年内中心导管相关血流感染(CLABSI)的发生率。

方法

实施工作在加利福尼亚南部一家四级医疗机构的急性护理和血液肿瘤儿科病房进行。通过 CVC 审核表来量化依从率,在实施前和实施后的第 1、2、3、4、5 年的每个季度都获得 CLABSI 发生率。

结果

在五年期间,两个儿科病房的 CLABSI 发生率都有所下降。干预措施不同特征的依从率为 90%至 100%;依从率最低的是患者防护设备(PPE)。在成立“虫虫大作战委员会”之前的一年共报告了 41 例医院获得性 CLABSI,此后该数字稳步下降至实施后的 9 例。儿科急性护理的季度 CLABSI 发生率从实施前的每千导管日 2.8 至 6.6 例,到实施后的每千导管日 2.1 至 4.3 例;儿科血液肿瘤的季度 CLABSI 发生率从实施前的每千导管日 2.1 至 4.3 例,到实施后的每千导管日 1.3 至 3.3 例。

结论

尽管医护人员的依从率仍然很高,但家长/家属的依从率较低。我们建议在多层面干预措施中纳入针对家长依从性的程序,例如患者教育手册、入院时审查内容、在门上张贴表示 PPE 要求的标志,并及时向不遵守规定的家属提供 PPE。

相似文献

1
Multi-level Intervention Program - A Quality Improvement Initiative to Decrease Central Line-Associated Bloodstream Infections in the Pediatric Acute and Hematology/Oncology Units.多层面干预方案 - 一项旨在降低儿科急症和血液肿瘤病房中心静脉相关血流感染率的质量改进计划。
J Pediatr Nurs. 2019 Sep-Oct;48:106-113. doi: 10.1016/j.pedn.2019.07.002. Epub 2019 Aug 1.
2
Preventing CLABSIs among pediatric hematology/oncology inpatients: national collaborative results.预防儿科血液学/肿瘤学住院患者中心静脉导管相关血流感染:全国协作结果
Pediatrics. 2014 Dec;134(6):e1678-85. doi: 10.1542/peds.2014-0582. Epub 2014 Nov 17.
3
Implementation of a central line maintenance care bundle in hospitalized pediatric oncology patients.在住院儿科肿瘤患者中实施中心静脉置管维护护理包。
Pediatrics. 2012 Oct;130(4):e996-e1004. doi: 10.1542/peds.2012-0295. Epub 2012 Sep 3.
4
Central line maintenance bundles and CLABSIs in ambulatory oncology patients.中心静脉置管维护套件与门诊肿瘤患者的 CLABSI
Pediatrics. 2013 Nov;132(5):e1403-12. doi: 10.1542/peds.2013-0302. Epub 2013 Oct 7.
5
Rapid cycle development of a multifactorial intervention achieved sustained reductions in central line-associated bloodstream infections in haematology oncology units at a children's hospital: a time series analysis.儿童医院血液肿瘤病房多因素干预措施的快速循环开发实现了中心静脉导管相关血流感染的持续减少:一项时间序列分析
BMJ Qual Saf. 2016 Aug;25(8):633-43. doi: 10.1136/bmjqs-2015-004450. Epub 2015 Nov 25.
6
The impact of central line bundles on the timing of catheter-associated bloodstream infections and their microbiological distribution in critically ill children.中心静脉导管套件对危重症患儿导管相关血流感染发生时间及其微生物分布的影响。
Eur J Pediatr. 2023 Oct;182(10):4625-4632. doi: 10.1007/s00431-023-05141-7. Epub 2023 Aug 9.
7
Impact of a Best Practice Prevention Bundle on Central Line-associated Bloodstream Infection (CLABSI) Rates and Outcomes in Pediatric Hematology, Oncology, and Hematopoietic Cell Transplantation Patients in Inpatient and Ambulatory Settings.最佳实践预防套件对住院和门诊环境中儿科血液学、肿瘤学和造血细胞移植患者中心静脉相关血流感染(CLABSI)率和结局的影响。
J Pediatr Hematol Oncol. 2021 Jan;43(1):e64-e72. doi: 10.1097/MPH.0000000000001950.
8
Reduction of central line-associated bloodstream infections in a pediatric hematology/oncology population.降低儿科血液学/肿瘤学患者群体中中心静脉导管相关血流感染的发生率。
Am J Med Qual. 2014 Nov-Dec;29(6):484-90. doi: 10.1177/1062860613509401. Epub 2013 Nov 13.
9
Bloodstream infections in pediatric oncology outpatients: a new healthcare systems challenge.儿科肿瘤门诊患者的血流感染:医疗系统面临的新挑战。
Infect Control Hosp Epidemiol. 2002 May;23(5):239-43. doi: 10.1086/502042.
10
Central line bundle including split-septum device and single-use prefilled flushing syringes to prevent port-associated bloodstream infections: a cost and resource-utilization analysis.中央导管套件包括分体式分隔装置和一次性预充冲洗注射器,以预防端口相关血流感染:成本和资源利用分析。
BMC Health Serv Res. 2020 Apr 21;20(1):336. doi: 10.1186/s12913-020-05221-6.

引用本文的文献

1
Central-line-associated bloodstream infections and central-line-associated non-CLABSI complications among pediatric oncology patients.儿科肿瘤患者的中心静脉导管相关血流感染和中心静脉导管相关非 CLABSI 并发症。
Infect Control Hosp Epidemiol. 2023 Mar;44(3):377-383. doi: 10.1017/ice.2022.91. Epub 2022 Apr 27.